tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

INDP Stock Latest News

Indaptus Therapeutics announces anticipated milestones in 1H of 2025
The FlyIndaptus Therapeutics announces anticipated milestones in 1H of 2025
10d ago
INDP
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
PremiumThe Fly
Indaptus Therapeutics files to sell 1.94M shares of common stock for holders
25d ago
INDP
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
PremiumThe Fly
Indaptus to sell 1.82M shares at $1.175 in registered direct offering
2M ago
INDP
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
PremiumThe Fly
Indaptus Therapeutics price target lowered to $5 from $8 at Maxim
2M ago
INDP
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
PremiumThe Fly
Indaptus Therapeutics reports Q3 EPS (32c) vs. (47c) last year
2M ago
INDP
Indaptus Therapeutics sees cash runway into 1Q25
PremiumThe FlyIndaptus Therapeutics sees cash runway into 1Q25
2M ago
INDP
Indaptus Therapeutics publishes research in Frontiers in Immunology
Premium
The Fly
Indaptus Therapeutics publishes research in Frontiers in Immunology
2M ago
INDP
Indaptus Therapeutics completes safety, PK, biomarker data on Decoy20
Premium
The Fly
Indaptus Therapeutics completes safety, PK, biomarker data on Decoy20
2M ago
INDP
Indaptus Therapeutics announces clinical supply agreement with BeiGene
PremiumThe Fly
Indaptus Therapeutics announces clinical supply agreement with BeiGene
3M ago
BGNE
INDP
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
PremiumThe Fly
Indaptus initiates unrestricted enrollment on patients on Decoy20 weekly dosing
3M ago
INDP
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
PremiumThe Fly
Indaptus Therapeutics CSO to speak on webinar about cancer immunotherapy
3M ago
INDP
Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
PremiumThe Fly
Indaptus Therapeutics files to sell 1.64M shares of common stock for holders
4M ago
INDP
Indaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose
PremiumThe FlyIndaptus Therapeutics to initiate dosing of patients at higher Decoy20 dose
4M ago
INDP
Indaptus Therapeutics sees cash runway into 1Q25
Premium
The Fly
Indaptus Therapeutics sees cash runway into 1Q25
5M ago
INDP
Indaptus Therapeutics reports Q2 EPS (47c) vs. (39c) last year
Premium
The Fly
Indaptus Therapeutics reports Q2 EPS (47c) vs. (39c) last year
5M ago
INDP
Indaptus Therapeutics announces $3M registered direct offering
PremiumThe Fly
Indaptus Therapeutics announces $3M registered direct offering
5M ago
INDP
Indaptus Therapeutics Elects Directors and Approves Key Proposals
PremiumCompany Announcements
Indaptus Therapeutics Elects Directors and Approves Key Proposals
7M ago
8K
INDP
Indaptus Therapeutics announces updated data from Phase 1 Decoy20 trial
PremiumThe Fly
Indaptus Therapeutics announces updated data from Phase 1 Decoy20 trial
8M ago
INDP
Indaptus Therapeutics to present new cohort data on Phase 1 trial of Decoy20
PremiumThe Fly
Indaptus Therapeutics to present new cohort data on Phase 1 trial of Decoy20
8M ago
INDP
Indaptus announces successful advancement of Phase 1 trial for Decoy20
PremiumThe FlyIndaptus announces successful advancement of Phase 1 trial for Decoy20
8M ago
INDP
Indaptus Therapeutics reports Q1 EPS (45c) vs (51c) last year
Premium
The Fly
Indaptus Therapeutics reports Q1 EPS (45c) vs (51c) last year
8M ago
INDP
Indaptus presents mechanism of action data at AACR for Decoy platform
Premium
The Fly
Indaptus presents mechanism of action data at AACR for Decoy platform
9M ago
INDP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >